Fulgent to Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
02/23/2023 - 04:05 PM
TEMPLE CITY, Calif. --(BUSINESS WIRE)--
Fulgent, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that members of its management team are scheduled to participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference on Tuesday, March 7, 2023 .
These representatives of the company will conduct a presentation beginning at approximately 8:05 a.m. Eastern Time (5:05 a.m. Pacific Time ).
A live webcast of the session will be available on the Investor Relations section of the Fulgent Genetics website at ir.fulgentgenetics.com . A replay of the webcast will be accessible at the same location beginning approximately one hour following the completion of the event.
About Fulgent
Fulgent is a technology-based company with a well-established clinical diagnostic business and a therapeutic development business. Fulgent’s clinical diagnostic business offers molecular diagnostic testing services, comprehensive genetic testing, and high-quality anatomic pathology laboratory services designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Fulgent’s therapeutic development business is focused on developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company aims to transform from a genomic diagnostic business into a fully integrated precision medicine company.
View source version on businesswire.com : https://www.businesswire.com/news/home/20230221005256/en/
Investor Relations Contacts:
The Blueshirt Group
Melanie Solomon , melanie@blueshirtgroup.com
Source: Fulgent, Inc.
FLGT Rankings
#4291 Ranked by Stock Gains
FLGT Stock Data
Industry
Dental Laboratories
Sector
Manufacturing
Tags
Health Services, Medical/Nursing Services, Manufacturing, Dental Laboratories
Country
US
City
Temple City
About FLGT
mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques
